HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement of postischemic contractile dysfunction of dog heart by MCI-154, a novel cardiotonic agent.

Abstract
The effects of MCI-154, a cardiotonic agent which has direct effects on cardiac myofilaments, on postischemic contractile dysfunction were studied in dog heart subjected to a 30-min occlusion of the left anterior descending coronary artery followed by reperfusion, and compared with the effects of milrinone and dobutamine, that have largely cyclic AMP-dependent mechanisms of action. Regional myocardial contractility (segment shortening) and tissue ATP levels were severely depressed in reperfused myocardium. MCI-154 (0.3 and 1 microgram/kg per min) improved the regional function of postischemic myocardium and decreased left ventricular end-diastolic pressure and systemic aortic pressure when infused i.v. from 30 min after reperfusion. The improvement of regional function caused by MCI-154 (1 microgram/kg per min) was more pronounced than that caused by milrinone (1 microgram/kg per min) or dobutamine (1 microgram/kg per min), although the drugs produced an equal increase in cardiac performance (peak positive left ventricular dP/dt). These results suggest that MCI-154 produces a more pronounced improvement of regional myocardial function than milrinone and dobutamine, presumably by increasing the responses of the contractile protein system to Ca2+. In this respect, MCI-154 would be of much benefit for the treatment of postischemic left ventricular dysfunction.
AuthorsY Abe, Y Kitada, A Narimatsu, A Tobe
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 192 Issue 2 Pg. 279-85 (Jan 10 1991) ISSN: 0014-2999 [Print] Netherlands
PMID2032560 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Cardiotonic Agents
  • Pyridazines
  • Pyridones
  • Dobutamine
  • Adenosine Triphosphate
  • MCI 154
  • Milrinone
  • Calcium
Topics
  • Adenosine Triphosphate (metabolism)
  • Animals
  • Calcium (metabolism)
  • Cardiotonic Agents (pharmacology, therapeutic use)
  • Coronary Disease (drug therapy, physiopathology)
  • Dobutamine (therapeutic use)
  • Dogs
  • Female
  • Hemodynamics (drug effects)
  • Male
  • Milrinone
  • Myocardial Contraction (drug effects)
  • Myocardium (metabolism)
  • Pyridazines (pharmacology, therapeutic use)
  • Pyridones (therapeutic use)
  • Ventricular Function, Left (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: